Soluble thrombomodulin plasma levels are an early indication of a lethal course in human acute pancreatitis

Surgery

Volumn 131, Issue 4, 2002, Pages 424-432

  Mantke, Rene ^a,b   Pross, Matthias ^a,b   Kunz, Dagmar ^a,b   Ebert, Matthias ^a,b   Kahl, Stephan ^a,b   Peters, Brigitte ^a,b   Malfertheiner, Peter ^a,b   Lippert, Hans ^a,b   Schulz, Hans Ulrich ^a,b  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; THROMBOMODULIN;

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; DYING; EARLY DIAGNOSIS; FEMALE; HIGH RISK PATIENT; HUMAN; INTENSIVE CARE; LETHALITY; MALE; PAIN ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY;

EID: 0036216787     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2002.122379     Document Type: Article

References (52)

1. Early assessment of severity in acute pancreatitis
2. A clinically based classification system for acute pancreatitis
3. A single centre double blind trial of trasylol therapy in primary acme pancreatitis
4. Biliary surgery in the same admission for gallstone-associated acute pancreatitis
5. Prognostic signs and the role of operative management in acute pancreatitis
6. C-reactive protein, antiproteases and complement factors as objective markers of severity in acute pancreatitis
7. Sensitivity of antiproteases, complement factors and C-reactive protein in detecting pancreatic necrosis: Results of a prospective clinical study
8. C-reactive protein: An aid to assessment and monitoring of acute pancreatitis
9. Serum C-reactive protein in acute biliary pancreatitis: Is it a reliable marker for the early assessment of severity of the disease?
10. Hepatocyte growth factor in assessment of acute pancreatitis: Comparison with C-reactive protein and interlenkin-6
11. PMN-elastase in comparison with CRP, antiproteases, and LDH as indicators of necrosis in human acute pancreatitis
12. Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis
13. Inflammatory mediators and cytokines: New aspects of the pathophysiology and assesment of severity of acute pancreatitis
14. Protein C and the endothelium
15. Plasma thrombomodulin in health and diseases
16. Elevated serum levels and reduced immunohistochemical expression of thrombomodulin in active ulcerative colitis
17. Thrombomudolin in intensive care patients
18. Increased plasma levels of soluble thrombomodulin in patients with sepsis and organ failure
19. Endothelial cell injury, as quantified by the soluble thrombomodulin level, predicts sepsis/multiple organ dysfunction syndrome after blunt trauma
20. Cytokines, soluble thrombomodulin and disseminated intravascular coagulation in patients with systemic inflammatory response syndrome
21. Increased circulating thrombomodulin in children with septic shock
22. Relationships between plasma levels of type-II phospholipase A2, PAF-acetylhydrolase, leukotriene B4, complements, endothelin-1, and thrombomodulin in patients with sepsis
23. Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuries
24. "Sensitivity" and "specificity" reconsidered: The meaning of these terms in analytical and diagnostic settings
25. Prognostic factors in acute pancreatitis
26. Prediction of outcome in acute pancreatitis: A comparative study of APACHE II, clinical assessment and multiple factor scoring systems
27. Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis
28. Inflammatory mediators in acute pancreatitis
29. Cytokines and acute pancreatitis
30. The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis
31. Methemalbumin in acute pancreatitis: An evaluation of its prognostic value and comparison with multiple prognostic parameters
32. Serum ribonuclease activity in the diagnosis of pancreatic disease
33. Prognostic factors in acute pancreatitis
34. Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: A multicentre study
35. Procalcitonin strip test in the early detection of severe acute pancreatitis
36. Activation peptide of carboxypeptidase B and anionic trypsinogen as early predictors of the severity of acute pancreatitis
37. Clinical usefulness of polymorphonuclear elastase in predicting the severity of acute pancreatitis: Results of a multicentre study
38. Role of interleukin-6 in acute pancreatitis: Comparison with C-reactive protein and phospholipase A
39. Interleukin-6 is a useful marker for early prediction of severity of acute pancreatitis
40. Evaluation of phospholipase A2 measurement for early prediction of severity of acute pancreatitis
41. Thrombomodulin, an endothelial anticoagulant: Its structure, function an expression
42. The role of thrombomodulin in the regulation of hemostatic interactions
43. Plasma levels of soluble thrombomodulin increase in cases of disseminated intravascular coagulation with organ failure
44. Plasma thrombomodulin is originated by damage of endothelial cell
45. Levels of plasma thrombomodulin are increased in atheromatous arterial disease
46. Elevated circulating thrombomodulin in severe preeclampsia
47. Plasma thrombomodulin concentrations in relation to cardiovascular risk factors in a population sample
48. Altered immune function in acute pancreatitis: Pathogenetic role and prognostic indicator?
49. Zelluläre und humorale funktionen bei der akuten pankreatitis
50. Acute-phase proteins and other systemic responses to inflammation
51. Monitoring of serum proteinase-antiproteinase balance and systemic inflammatory response in the prognostic evaluation of acute pancreatitis: Results of a prospective multicenter study
52. A prospective audit against national standards of the presentation and management of acute pancreatitis in the South of England